Interestingly, we observed an upregulation of hsa-miR-221-5p in both the A+(T|N)+ signature and the conversion from MCI to AD, potentially serving as a mechanism to decrease ADAM10 and favour AD pathology. The gene discussed is ADAM10; the disease is Alzheimer disease.